CLASS I ONGOING Drug recall · Reported 17 Apr 2024 · FDA Enforcement Report
Methocarbamol Injection, USP 1000mg recalled by Eugia US
Eugia US is recalling Methocarbamol Injection, USP 1000mg/, (100mg/mL) Single-Dose Vial packed 25 vials per, distributed nationwide in the US. The recall was initiated on 15 Feb 2024 and the FDA has classified it as Class I.
Check your package
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
Recall details
- Recall number
- D-0440-2024
- FDA event ID
- 94025
- Recalling firm
- Eugia US, East Windsor, NJ
- Brand
- Methocarbamol
- Manufacturer
- Eugia US LLC
- Classification
- Class I
- Status
- Ongoing
- Recall initiated
- 15 Feb 2024
- FDA classified
- 8 Apr 2024
- Reported
- 17 Apr 2024
- Type
- Voluntary: Firm initiated
- Customers notified by
- Letter
- Reason category
- Particulate Matter
- Drug class
- Injectable & IV Drugs
Timeline
| 15 Feb 2024 | Recall initiated by company | |
| 8 Apr 2024 | Classified by FDA | +53 days |
| 17 Apr 2024 | Published in enforcement report | +9 days |
Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.
Reason for recall
Presence of Particulate Matter
Product as listed by the FDA
Methocarbamol Injection, USP 1000mg/10mL, (100mg/mL), 10 mL Single-Dose Vial packed 25 vials per carton, Rx Only, Mfd. in India for: Eugia US LLC. E. Windsor, NJ 08520, NDC 55150-223-10
Where it was distributed
Nationwide in the USA
Questions about this recall
Why was it recalled?
Presence of Particulate Matter
Which lots are affected?
Lot #: 3MC23011, Exp 11/30/2026
Where was it sold?
Nationwide in the USA
What should I do if I have it?
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
What does Class I mean?
Class I is the most serious FDA recall category: there is a reasonable probability that using the product will cause serious health consequences or death.
Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.
More recalls from Eugia US
All 17| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS III | Lidocaine HCl Injection, USP 2%, 40 mg recalled by Eugia USLidolog Kit | Eugia US | Other | Nationwide |
| Drug | CLASS II | Gentamicin Injection, USP, (Pediatric), 20 mg recalled by Eugia USGentamicin | Eugia US | Potency & Assay | Nationwide |
| Drug | CLASS II | Tirofiban Hydrochloride Injection 5 mg recalled by Eugia USTirofiban | Eugia US | Potency & Assay | Nationwide |
| Drug | CLASS II | Tirofiban Hydrochloride Injection 12.5 mg recalled by Eugia USTirofiban | Eugia US | Potency & Assay | Nationwide |
| Drug | CLASS II | Testosterone Cypionate Injection, USP, CIII, 200mg per mL recalledTestosterone Cypionate | Eugia US | Manufacturing (CGMP) Deviations | Nationwide |
Other Methocarbamol recalls
All 7| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Methocarbamol Injection USP 1,000 mg/ (100 mg/mL) Single Dose Vial recalledMethocarbamol | Somerset Therapeutics Private | Sterility | Nationwide |
| Drug | CLASS I | Methocarbamol 500mg Tablet recalled by Bryant Ranch Prepack | Bryant Ranch Prepack | Packaging Defects | Nationwide |
| Drug | CLASS II | Methocarbamol recalled by American Pharmaceutical | American Pharmaceutical Ingredients | Manufacturing (CGMP) Deviations | Nationwide |
| Drug | CLASS III | Methocarbamol Tablets, USP 500 mg recalled | Golden State Medical Supply | Packaging Defects | GA |
| Drug | CLASS II | Methocarbamol, Tablet, 500 mg recalled by Aidapak Services | Aidapak Services | Labeling Errors | 4 states |